363 related articles for article (PubMed ID: 29388517)
1. A brief history of antidepressant drug development: from tricyclics to beyond ketamine.
Pereira VS; Hiroaki-Sato VA
Acta Neuropsychiatr; 2018 Dec; 30(6):307-322. PubMed ID: 29388517
[TBL] [Abstract][Full Text] [Related]
2. What is the mechanism of Ketamine's rapid-onset antidepressant effect? A concise overview of the surprisingly large number of possibilities.
Strasburger SE; Bhimani PM; Kaabe JH; Krysiak JT; Nanchanatt DL; Nguyen TN; Pough KA; Prince TA; Ramsey NS; Savsani KH; Scandlen L; Cavaretta MJ; Raffa RB
J Clin Pharm Ther; 2017 Apr; 42(2):147-154. PubMed ID: 28111761
[TBL] [Abstract][Full Text] [Related]
3. A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action.
Naughton M; Clarke G; O'Leary OF; Cryan JF; Dinan TG
J Affect Disord; 2014 Mar; 156():24-35. PubMed ID: 24388038
[TBL] [Abstract][Full Text] [Related]
4. Potential involvement of serotonergic signaling in ketamine's antidepressant actions: A critical review.
du Jardin KG; Müller HK; Elfving B; Dale E; Wegener G; Sanchez C
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Nov; 71():27-38. PubMed ID: 27262695
[TBL] [Abstract][Full Text] [Related]
5. [A review of the antidepressant properties of ketamine].
Desfossés CY; Blier P
Med Sci (Paris); 2021 Jan; 37(1):27-34. PubMed ID: 33492215
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of ketamine action as an antidepressant.
Zanos P; Gould TD
Mol Psychiatry; 2018 Apr; 23(4):801-811. PubMed ID: 29532791
[TBL] [Abstract][Full Text] [Related]
7. Ketamine: Leading us into the future for development of antidepressants.
Carreno FR; Lodge DJ; Frazer A
Behav Brain Res; 2020 Apr; 383():112532. PubMed ID: 32023492
[TBL] [Abstract][Full Text] [Related]
8. Depression and antidepressant action-from molecules to networks.
Rantamäki T; Yalcin I
Cell Tissue Res; 2019 Jul; 377(1):1-4. PubMed ID: 31073906
[No Abstract] [Full Text] [Related]
9. Toward specific ways to combine ketamine and psychotherapy in treating depression.
Hasler G
CNS Spectr; 2020 Jun; 25(3):445-447. PubMed ID: 31213212
[TBL] [Abstract][Full Text] [Related]
10. The rapid-onset antidepressant effect of ketamine: More surprises?
Raffa RB; Pergolizzi JV; Taylor R;
J Clin Pharm Ther; 2018 Apr; 43(2):308-311. PubMed ID: 29178131
[TBL] [Abstract][Full Text] [Related]
11. Rapid-onset antidepressant action of ketamine: potential revolution in understanding and future pharmacologic treatment of depression.
Drewniany E; Han J; Hancock C; Jones RL; Lim J; Nemat Gorgani N; Sperry JK; Yu HJ; Raffa RB
J Clin Pharm Ther; 2015 Apr; 40(2):125-30. PubMed ID: 25545040
[TBL] [Abstract][Full Text] [Related]
12. [Ketamine's antidepressant effect: focus on ketamine mechanisms of action].
De Maricourt P; Jay T; Goncalvès P; Lôo H; Gaillard R
Encephale; 2014 Feb; 40(1):48-55. PubMed ID: 24434007
[TBL] [Abstract][Full Text] [Related]
13. Changes in neurotrophic signaling pathways in brain areas of the chronic mild stress rat model of depression as a signature of ketamine fast antidepressant response/non-response.
Derosa S; Misztak P; Mingardi J; Mazzini G; Müller HK; Musazzi L
Prog Neuropsychopharmacol Biol Psychiatry; 2024 Jan; 128():110871. PubMed ID: 37793481
[TBL] [Abstract][Full Text] [Related]
14. Ketamine for Treatment-Resistant Depression: a New Advocate.
Pérez-Esparza R
Rev Invest Clin; 2018; 70(2):65-7. PubMed ID: 29718013
[TBL] [Abstract][Full Text] [Related]
15. Ketamine for Depression: Advances in Clinical Treatment, Rapid Antidepressant Mechanisms of Action, and a Contrast with Serotonergic Psychedelics.
Kojic M; Saelens J; Kadriu B; Zarate CA; Kraus C
Curr Top Behav Neurosci; 2022; 56():141-167. PubMed ID: 35312993
[TBL] [Abstract][Full Text] [Related]
16. Two cellular hypotheses explaining the initiation of ketamine's antidepressant actions: Direct inhibition and disinhibition.
Miller OH; Moran JT; Hall BJ
Neuropharmacology; 2016 Jan; 100():17-26. PubMed ID: 26211972
[TBL] [Abstract][Full Text] [Related]
17. Novel Insights Into the Neurobiology of the Antidepressant Response From Ketamine Research: A Mini Review.
Colla M; Scheerer H; Weidt S; Seifritz E; Kronenberg G
Front Behav Neurosci; 2021; 15():759466. PubMed ID: 34924969
[TBL] [Abstract][Full Text] [Related]
18. The next psychoactive drugs: From imipramine to ketamine.
Carrillo P; Petit AC; Gaillard R; Vinckier F
Bull Acad Natl Med; 2020 Dec; 204(9):e169-e177. PubMed ID: 36879561
[TBL] [Abstract][Full Text] [Related]
19. Targeting of NMDA receptors in the treatment of major depression.
Dang YH; Ma XC; Zhang JC; Ren Q; Wu J; Gao CG; Hashimoto K
Curr Pharm Des; 2014; 20(32):5151-9. PubMed ID: 24410564
[TBL] [Abstract][Full Text] [Related]
20. Glutamate-Based Drug Discovery for Novel Antidepressants.
Pałucha-Poniewiera A; Pilc A
Expert Opin Drug Discov; 2016 Sep; 11(9):873-83. PubMed ID: 27409299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
